‹ ›
MYP_163121
← PREVIOUS NEXT → BACK
Basic Information
F44
Antimicrobial
Antiviral
Antiviral ▸ Antiviral mechanism ▸ Viral entry inhibition ▸ Entry inhibitor
Antiviral ▸ Antiviral mechanism ▸ Viral fusion inhibition ▸ Fusion inhibitor
Standard
17 amino acids
C84H132N26O27S2
Standard
Sequence
KEGSNICLTRTDRGWYC
Physicochemical Analysis
2002.23 Da
8.05
0.74
0.51
0.0437
-0.90
0.48
-0.25
44.42
45.88
0.1176
6990.00
7115.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
893.14
-10.33
35.0
30.0
65.0
139.0
3.0
17.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0077457 VERIFIED: YES
Provenance & Taxonomy
Human orthopneumovirus [Virus]
Virus-derived peptide
11250;0
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral Entry inhibitor Fusion inhibitor
Respiratory syncytial virus (Virus entry); Vero
Flow cytometry
PaperIdentification of linear heparin-binding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivity. | Crim RL, Audet SA, Feldman SA, Mostowski HS, Beeler JA. | J Virol. 2007 | PMID:17050595 PMID17050595 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/17050595/
RECORD: Rec_0303083 VERIFIED: YES
Provenance & Taxonomy
not reported [other]
Structure & Mods
linear peptide; DSSP H 0.0%, E 0.0%, T 52.9%, C 47.1% [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Antimicrobial
PaperAVPdb: a database of experimentally validated antiviral peptides targeting medically important viruses PMID24285301 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/24285301/